Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.Drugs (Pharmaceuticals), Yeast Infections, Women and Girls, Food and Drug Administration, SCYNEXIS Inc., your-feed-scienceRead More
